文献速递乳腺癌放疗

肿瘤分级与分子亚型对乳腺癌放疗局部控制的影响:分次方案真的重要吗?一项回顾性对照组研究

Tumor grade and molecular subtypes on local control in breast cancer radiotherapy: Does fractionation really matter? A retrospective control study group.
PubMed 文献 · Clin Transl Radiat Oncol · 2018-11-27

该回顾性对照组研究纳入215例2008至2011年在本机构接受大分割放疗的患者,与215例接受标准放疗的患者比较。中位随访9.5年(7-13年),两组8年无局部复发生存率无统计学显著差异(P=.836)。单因素分析中3级肿瘤仅与标准放疗组局部复发显著相关(P=.041);多因素分析证实Her2非管腔亚型是局部复发的独立因素(P=.045),与分次方案无关。

要点

  • 两组8年无局部复发生存率无统计学显著差异(P=.836)。
  • 3级肿瘤仅与标准放疗组局部复发显著相关(P=.041)。
  • Her2非管腔亚型是局部复发的独立因素(P=.045),与分次方案无关。

核心结论

  • 乳腺癌亚型显示不同的放射敏感性,且该差异与分次方案无关。

研究设计与样本

  • 回顾性对照组研究,215例2008至2011年在本机构接受大分割放疗的患者资料为前瞻性收集,与215例接受标准放疗的对照组患者比较。

主要发现

  • 中位随访9.5年(7-13年),两组8年无局部复发生存率无统计学显著差异(P=.836)。
  • 单因素Cox分析中,3级肿瘤仅在大分割放疗组与局部复发显著相关(P=.041)。
  • 单因素分析中,各分子亚型间未发现差异;Her2+非管腔亚型无差异(P=.233)。
  • 多因素分析证实Her2非管腔亚型是局部复发的独立变量,与分次方案无关(P=.045)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this current study was to assess whether the tumour grade and molecular subtypes have influenced local control in the whole breast hypofractionated radiotherapy (HRT) over standard radiotherapy (SRT) in early breast node negative cancer patients by a retrospective control group study. Data of 215 patients treated with hypofractionated radiotherapy at our institution from 2008 to 2011 were prospectively collected and then compared with 215 pts treated with SRT in a control group study. The local relapse free survival (LRFS) in both arms was compared on the basis of variables defined by tumour grade (Nottingham Grading System), and Molecular subtypes. Kaplan-Meier method was applied to estimate the LRFS in both groups. Chi-squared and univariate Cox proportional hazards model were conducted for all variables in both groups to assess the impact on local control. Statistical significance was assumed at P < .05. Statistical significant variables at univariate analysis were then included in multivariate Cox proportional hazards model. The median follow up duration was 9.5 years (7-13 yrs); the Kaplan Meyer 8 year LRFS did not reach any statistical significant difference between the two groups (P = . 836). At univariate Cox analysis tumour grade 3 was significantly related to local relapse only in the SRT group (P = .041) while, among molecular subtypes, no differences were found for all groups; for Her2 + noL no difference was found (P = .233). Multivariate analysis confirmed Her2 non-luminal subtype as an independent variable for local relapse regardless the fractionation arm (P = .045). Breast cancer subtypes show a different radiosensitivity, which is independent by fractionation.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Lazzari G, Terlizzi A, Leo MG, et al. Tumor grade and molecular subtypes on local control in breast cancer radiotherapy: Does fractionation really matter? A retrospective control study group. Clin Transl Radiat Oncol. 2018. PMID: 30582015. doi:10.1016/j.ctro.2018.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。